发明授权
US08445667B2 SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
有权
靶向细胞周期蛋白依赖性激酶抑制剂1B（p27，Kip1）（CDKN1B）
- 专利标题： SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
- 专利标题（中）： 靶向细胞周期蛋白依赖性激酶抑制剂1B（p27，Kip1）（CDKN1B）
-
申请号： US13531657申请日： 2012-06-25
-
公开(公告)号： US08445667B2公开(公告)日： 2013-05-21
- 发明人: Anastasia Khvorova , Angela Reynolds , Devin Leake , William Marshall , Steven Read , Stephen Scaringe
- 申请人： Anastasia Khvorova , Angela Reynolds , Devin Leake , William Marshall , Steven Read , Stephen Scaringe
- 申请人地址： US CO Lafayette
- 专利权人： Dharmacon, Inc.
- 当前专利权人： Dharmacon, Inc.
- 当前专利权人地址： US CO Lafayette
- 代理机构： Dorf & Nelson LLP
- 代理商 Scott D. Locke, Esq.
- 主分类号： C07H21/04
- IPC分类号： C07H21/04 ; C07H21/02
摘要：
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for CDKN1B.
公开/授权文献
信息查询
